[(2S,3R,4R,5S,6R)-3-Acetamido-5-hydroxy-2-[(2R,3S,4R,5R,6S)-5-hydroxy-2-(hydroxymethyl)-4-sulfooxy-6-[(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxan-4-yl] hydrogen sulfate

Term ID

CHEBI:148533

Synonyms

2-acetamido-2-deoxy-3-O-sulfo-beta-D-galacto-hexopyranosyl-(1->4)-3-O-sulfo-beta-D-galacto-hexopyranosyl-(1->4)-beta-D-gluco-hexopyranose
GalNAc3S(b1-4)Gal3S(b1-4)b-Glc
WURCS=2.0/3,3,2/[a2122h-1b_1-5][a2112h-1b_1-5_3*OSO/3=O/3=O][a2112h-1b_1-5_2*NCC/3=O_3*OSO/3=O/3=O]/1-2-3/a4-b1_b4-c1

Definition

References

GlyGen:G28868PL
GlyTouCan:G28868PL

Ontology

ChEBI ( EBI )

Relationships

is a type of: oligosaccharide

oligosaccharide Show first 5 Terms

Phenotype

Phenotype resulting from [(2S,3R,4R,5S,6R)-3-Acetamido-5-hydroxy-2-[(2R,3S,4R,5R,6S)-5-hydroxy-2-(hydroxymethyl)-4-sulfooxy-6-[(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxan-4-yl] hydrogen sulfate

Phenotype where environments contain [(2S,3R,4R,5S,6R)-3-Acetamido-5-hydroxy-2-[(2R,3S,4R,5R,6S)-5-hydroxy-2-(hydroxymethyl)-4-sulfooxy-6-[(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxan-4-yl] hydrogen sulfate

Phenotype modified by environments containing [(2S,3R,4R,5S,6R)-3-Acetamido-5-hydroxy-2-[(2R,3S,4R,5R,6S)-5-hydroxy-2-(hydroxymethyl)-4-sulfooxy-6-[(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxan-4-yl] hydrogen sulfate

Phenotype affecting [(2S,3R,4R,5S,6R)-3-Acetamido-5-hydroxy-2-[(2R,3S,4R,5R,6S)-5-hydroxy-2-(hydroxymethyl)-4-sulfooxy-6-[(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxan-4-yl] hydrogen sulfate

Human Disease Model